122 related articles for article (PubMed ID: 20403349)
1. Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).
Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
[TBL] [Abstract][Full Text] [Related]
2. IGD motifs, which are required for migration stimulatory activity of fibronectin type I modules, do not mediate binding in matrix assembly.
Maurer LM; Annis DS; Mosher DF
PLoS One; 2012; 7(2):e30615. PubMed ID: 22355321
[TBL] [Abstract][Full Text] [Related]
3. The role of the fibronectin IGD motif in stimulating fibroblast migration.
Millard CJ; Ellis IR; Pickford AR; Schor AM; Schor SL; Campbell ID
J Biol Chem; 2007 Dec; 282(49):35530-5. PubMed ID: 17921136
[TBL] [Abstract][Full Text] [Related]
4. Motogenic activity of IGD-containing synthetic peptides.
Schor SL; Ellis I; Banyard J; Schor AM
J Cell Sci; 1999 Nov; 112 ( Pt 22)():3879-88. PubMed ID: 10547349
[TBL] [Abstract][Full Text] [Related]
5. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract][Full Text] [Related]
6. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
Schor SL; Ellis IR; Jones SJ; Baillie R; Seneviratne K; Clausen J; Motegi K; Vojtesek B; Kankova K; Furrie E; Sales MJ; Schor AM; Kay RA
Cancer Res; 2003 Dec; 63(24):8827-36. PubMed ID: 14695199
[TBL] [Abstract][Full Text] [Related]
7. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
8. Motogenic sites in human fibronectin are masked by long range interactions.
Vakonakis I; Staunton D; Ellis IR; Sarkies P; Flanagan A; Schor AM; Schor SL; Campbell ID
J Biol Chem; 2009 Jun; 284(23):15668-75. PubMed ID: 19366708
[TBL] [Abstract][Full Text] [Related]
9. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
Houard X; Germain S; Gervais M; Michaud A; van den Brûle F; Foidart JM; Noël A; Monnot C; Corvol P
Int J Cancer; 2005 Sep; 116(3):378-84. PubMed ID: 15800942
[TBL] [Abstract][Full Text] [Related]
10. Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT.
Ellis IR; Jones SJ; Lindsay Y; Ohe G; Schor AM; Schor SL; Leslie NR
Cell Signal; 2010 Nov; 22(11):1655-9. PubMed ID: 20600851
[TBL] [Abstract][Full Text] [Related]
11. On-Off Kinetics of Engagement of FNI Modules of Soluble Fibronectin by β-Strand Addition.
Ma W; Ma H; Mosher DF
PLoS One; 2015; 10(4):e0124941. PubMed ID: 25919138
[TBL] [Abstract][Full Text] [Related]
12. Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI).
Jones SJ; Florence MM; Ellis IR; Kankova K; Schor SL; Schor AM
Exp Cell Res; 2007 Dec; 313(20):4145-57. PubMed ID: 17949711
[TBL] [Abstract][Full Text] [Related]
13. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin.
Schor SL; Ellis I; Dolman C; Banyard J; Humphries MJ; Mosher DF; Grey AM; Mould AP; Sottile J; Schor AM
J Cell Sci; 1996 Oct; 109 ( Pt 10)():2581-90. PubMed ID: 8923219
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing.
Ellis I; Grey AM; Schor AM; Schor SL
J Cell Sci; 1992 Jul; 102 ( Pt 3)():447-56. PubMed ID: 1506427
[TBL] [Abstract][Full Text] [Related]
16. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
17. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.
Sieg DJ; Ilić D; Jones KC; Damsky CH; Hunter T; Schlaepfer DD
EMBO J; 1998 Oct; 17(20):5933-47. PubMed ID: 9774338
[TBL] [Abstract][Full Text] [Related]
18. Borrelia burgdorferi protein BBK32 binds to soluble fibronectin via the N-terminal 70-kDa region, causing fibronectin to undergo conformational extension.
Harris G; Ma W; Maurer LM; Potts JR; Mosher DF
J Biol Chem; 2014 Aug; 289(32):22490-9. PubMed ID: 24962582
[TBL] [Abstract][Full Text] [Related]
19. Role of the heparin-binding domain of chimeric peptides derived from fibronectin in cell spreading and motility.
Yoneda J; Saiki I; Igarashi Y; Kobayashi H; Fujii H; Ishizaki Y; Kimizuka F; Kato I; Azuma I
Exp Cell Res; 1995 Mar; 217(1):169-79. PubMed ID: 7867715
[TBL] [Abstract][Full Text] [Related]
20. The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region-dependent nuclear sequestration of its precursor messenger RNA.
Kay RA; Ellis IR; Jones SJ; Perrier S; Florence MM; Schor AM; Schor SL
Cancer Res; 2005 Dec; 65(23):10742-9. PubMed ID: 16322219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
